A detailed history of Lcnb Corp transactions in Amgen Inc stock. As of the latest transaction made, Lcnb Corp holds 7,122 shares of AMGN stock, worth $2.09 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
7,122
Previous 7,169 0.66%
Holding current value
$2.09 Million
Previous $2.24 Million 2.46%
% of portfolio
0.82%
Previous 0.84%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$309.38 - $337.38 $14,540 - $15,856
-47 Reduced 0.66%
7,122 $2.29 Million
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $24,961 - $30,334
-95 Reduced 1.31%
7,169 $2.24 Million
Q1 2024

May 10, 2024

SELL
$268.87 - $324.56 $13,443 - $16,228
-50 Reduced 0.68%
7,264 $2.07 Million
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $9,205 - $10,384
36 Added 0.49%
7,314 $2.11 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $54,225 - $67,322
-248 Reduced 3.3%
7,278 $1.96 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $91,493 - $108,188
427 Added 6.01%
7,526 $1.67 Million
Q1 2023

May 03, 2023

BUY
$225.79 - $275.2 $89,187 - $108,704
395 Added 5.89%
7,099 $1.72 Million
Q4 2022

Feb 10, 2023

BUY
$229.03 - $291.01 $112,453 - $142,885
491 Added 7.9%
6,704 $1.76 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $5,835 - $6,581
26 Added 0.42%
6,213 $1.4 Million
Q2 2022

Aug 12, 2022

BUY
$230.71 - $256.74 $10,381 - $11,553
45 Added 0.73%
6,187 $1.51 Million
Q1 2022

May 13, 2022

BUY
$219.27 - $242.57 $66,000 - $73,013
301 Added 5.15%
6,142 $1.49 Million
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $62,846 - $71,921
316 Added 5.72%
5,841 $1.31 Million
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $16,981 - $19,896
80 Added 1.47%
5,525 $1.18 Million
Q2 2021

Aug 13, 2021

BUY
$233.58 - $259.14 $46,716 - $51,828
200 Added 3.81%
5,445 $1.33 Million
Q1 2021

May 13, 2021

BUY
$221.91 - $258.6 $29,514 - $34,393
133 Added 2.6%
5,245 $1.31 Million
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $5,866 - $6,523
-25 Reduced 0.49%
5,112 $1.3 Million
Q2 2020

Aug 12, 2020

SELL
$197.81 - $242.74 $15,429 - $18,933
-78 Reduced 1.5%
5,137 $1.21 Million
Q1 2020

May 11, 2020

BUY
$182.24 - $241.7 $112,077 - $148,645
615 Added 13.37%
5,215 $1.06 Million
Q4 2019

Feb 10, 2020

BUY
$189.21 - $243.2 $17,028 - $21,888
90 Added 2.0%
4,600 $1.11 Million
Q3 2019

Nov 08, 2019

BUY
$174.11 - $208.62 $23,156 - $27,746
133 Added 3.04%
4,510 $873,000
Q2 2019

Aug 01, 2019

BUY
$166.7 - $195.41 $19,337 - $22,667
116 Added 2.72%
4,377 $807,000
Q1 2019

May 02, 2019

BUY
$180.87 - $203.88 $65,113 - $73,396
360 Added 9.23%
4,261 $810,000
Q4 2018

Feb 19, 2019

BUY
$178.4 - $208.25 $1,605 - $1,874
9 Added 0.23%
3,901 $759,000
Q3 2018

Nov 09, 2018

SELL
$185.29 - $208.89 $14,267 - $16,084
-77 Reduced 1.94%
3,892 $807,000
Q2 2018

Aug 13, 2018

BUY
$166.05 - $186.51 $158,577 - $178,117
955 Added 31.69%
3,969 $733,000
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $6,777 - $7,920
40 Added 1.34%
3,014 $513,000
Q4 2017

Feb 13, 2018

SELL
$168.79 - $188.59 $843 - $942
-5 Reduced 0.17%
2,974 $517,000
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $24,591 - $28,077
147 Added 5.19%
2,979 $556,000
Q2 2017

Aug 14, 2017

BUY
N/A
2,832
2,832 $488,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $157B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Lcnb Corp Portfolio

Follow Lcnb Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lcnb Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lcnb Corp with notifications on news.